|
|
INTRODUCTION The global pharmaceutical industry is a knowledge-based industry. The pharmaceutical market is growing at 8% per year, and is forecast to grow to more than $800-billion by 2008. Aspirin has always been and still is the “Gold Standard” of pain relievers. Even so, in tablet and powder forms, it is acidic, non-soluble in water, and only about 35 to 40% of the drug ever gets into the blood stream. Because of this form, it is slow to be effective and causes side effects such as stomach bleeding and gastric upset. The scientists at PharmStar have been working for over 15 years to convert common aspirin tablets and powders into a much more therapeudically effective and safer form. What has been achieved is the most significant breakthrough in the pain reliever field in many decades. The potassium based derivative of aspirin, “ AQUAPRIN ” is the safest, most effective, and fastest acting form of aspirin worldwide and in fact most likely the superior OTC pain reliever worldwide. A truly soluble form of aspirin does not exist in the United States except for the very high sodium content Alka Seltzerâ which cannot be taken on a routine basis. Outside the US, the market for this product has more than a 2 billion dollar market. PharmStar’s mission is to be a highly profitable leader in the OTC and prescription pain management field, and to capture a lucrative segment of the Analgesic, Arthritic, Osteoporosis, cardio protective, and migraine market. AQUAPRIN and other line extension products, including the AQUAPRIN, 81 mg "DAILY REGIMEN" will have significant competitive and efficacious advantages over all other analgesics and OTC pain relievers and 81 mg daily regimen products. While aspirin is a miracle drug in so many respects, it is nevertheless acidic and insoluble in water causing, in millions of patients, severe gastric distress and, sometimes, hemorrhage owing to direct contact between un-dissolved solid, acidic aspirin particles, and the stomach lining. Indeed, it is precisely these gastro-toxic, ulcerogenic adverse-reactions that prevent many patients from taking full advantage of aspirin’s multi-faceted benefits. Since the aspirin-derivative salicylates in the AQUAPRIN 650 mg pain reliever is an antacid solution, and fully dissolved and residue free, solubilized active salicylates are immediately absorbed into the blood stream. AQUAPRIN‘s antacid characteristics help neutralize stomach acids, thus greatly virtually eliminating local topical and systemic gastric damage and irritation. In addition, salicylates in conventional aspirin tablets are degraded during their passage through the GI-tract and during metabolism achieving only 35 to 40% absorption efficiency. AQUAPRIN is administered in a great tasting 1.5 oz or more solution. It effectively delivers a much higher percentage of salicylates – with a commensurately magnified coefficient of analgesia and relief extremely fast and lasting longer than conventional Aspirin. Because of these attributes, lower doses of AQUAPRIN can achieve the same pain relieving effectiveness as aspirin tablets or aspirin powders. The AQUAPRIN "Daily Regimen" 81 mg product instantly dissolves in any drink and is tasteless. "PAIN-AWAY" is the same as AQUAPRIN but with added ingredients to accelerate pain relieving action. |
|||||||||||||||||||||||
